FDA panel recommends Pfizer’s low-dose Covid vaccine for kids ages 5 to 11

FDA panel endorses COVID-19 vaccine for kids

The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as a panel of government advisers on Tuesday endorsed kid-size doses of Pfizer’s shots for 5- to 11-year-olds.

Newsfeed Now: FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids; Man shaves beard for toddler’s cancer treatment

Weekdays at 10:30 a.m. CST/11:30 a.m. EST, Newsfeed Now will be streaming the top stories in the U.S. utilizing our newsrooms across the country. If you miss the live report, you’ll be able to see a replay minutes after the stream ends.(NEXSTAR) – Children as young as five are one step closer to being eligible to get a covid-19 vaccine. An FDA panel studied Pfizer's data on their pediatric vaccine and recommended it receive an emergency authoriz…

FDA panel recommends vaccine for young children

BAKERSFIELD, Calif. (KGET) — COVID vaccination for young children seems to be on its way. Tuesday, an Food and Drug Administration panel unanimously voted to recommend a Pfizer vaccine designed spe…

FDA Advisory Panel Recommends Pfizer COVID-19 Vaccine for Children 5-11 Years Old

An advisory panel of the U.S. Food and Drug Administration voted Tuesday to grant emergency authorization to Pfizer’s two-dose COVID-19 vaccine for children between the ages of 5 and 11 years old. Pfizer and its German-based partner BioNTech are seeking permission to inoculate children in this age group with a lower dose than what is currently given to people ages 12 and older.    The advisory panel voted 17-to-0, with one person declining to  v…

FDA recommends Pfizer vaccine for children

(WBRE/WYOU) — Thousands of children in our region could soon be eligible to receive a coronavirus vaccine. Tuesday night an FDA advisory committee has recommended the authorization of a lower dose …

Child-vaccine doses favored by FDA panel

WASHINGTON -- The U.S. moved a step closer to expanding covid-19 vaccinations for millions more children as government advisers Tuesday endorsed child-size doses of Pfizer's shots for 5- to 11-year-olds -- setting in motion a string of decisions that could lead to them getting shots as soon as late next week.